Skip to content
Bioptigen logo — Explore groundbreaking ophthalmic imaging without boundaries...

Bioptigen

Explore groundbreaking ophthalmic imaging without boundaries, from zebrafish to elephants, with our real-time, high-resolution, near-infrared technology.

Founded 2004 Venture round Total: $1.50M Biotechnology, Health Care +1

General Information

Company Name Bioptigen
Founded Year 2004
Founders / Decision Makers
Team member
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Bioptigen. To contact Bioptigen, visit bioptigen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Bioptigen compare?

A PDF of Bioptigen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Bioptigen soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Bioptigen

Bioptigen is an ISO 13485-certified medical device company specializing in creating advanced ophthalmic imaging solutions. The company's Envisu™ R-class systems offer non-invasive imaging capabilities for a wide range of animals, from zebrafish to elephants, using low-power, near-infrared light to produce real-time, high-resolution, volumetric images of eye structures. With CE approval obtained, Bioptigen is positioned to market its hand-held Envisu R2000 systems for preclinical use and C2000 systems for clinical applications within the EU. Since its foundation in 2004, Bioptigen has garnered significant attention within the Biotechnology, Health Care, and Medical Devices industries. The latest notable development for Bioptigen was a $1.50M Venture Round investment on 07 March 2011.

Business keywords: Ophthalmic Imaging, Near-Infrared Technology, ISO 13485 Certification, Envisu R-Class Systems, Biomedical Imaging, Animal Ocular Imaging, Preclinical Imaging, Clinical Imaging, Zebrafish, Elephants, Volumetric Imaging, CE Approval, Non-Invasive Imaging, Bioptigen Inc.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.50M -
07 Mar 2011

Bioptigen Alternatives & Competitors

View All Alternatives
Bioptigen vs
NearWave
NearWave United States

The NearWave Imager is a non-invasive imaging device for breast cancer detection and monitoring.

Seed
8 employees
Biotechnology, Health Care
Bioptigen vs
Heliosonix
Heliosonix United States

Imaging the Sound of Light!

1 employees
Health Care, Medical Devices
Bioptigen vs

Evolution in Surgery

Seed
11 employees
Biotechnology, Health Care

FAQ About Bioptigen

Explore groundbreaking ophthalmic imaging without boundaries, from zebrafish to elephants, with our real-time, high-resolution, near-infrared technology.
Bioptigen was founded in 2004.
Bioptigen operates in Biotechnology, Health Care and Medical Devices. Its work centres on Ophthalmic Imaging, Near-Infrared Technology, ISO 13485 Certification and Envisu R-Class Systems.
Bioptigen has completed 1 funding round, raising a total of $1.50M. The latest funding stage is Venture round.
Top alternatives and competitors to Bioptigen include NearWave, Heliosonix, Surglasses - Taiwan Main Orthopaedic Biotechnology Co., Ltd., PneumaCare Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Bioptigen and NearWave are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Bioptigen, https://bouncewatch.com/company/bioptigen, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout